Literature DB >> 30578966

A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program.

Anna Maria Giudetti1, Stefania De Domenico2, Andrea Ragusa3, Paola Lunetti1, Antonio Gaballo4, Julien Franck5, Pasquale Simeone6, Giuseppe Nicolardi1, Francesco De Nuccio1, Angelo Santino7, Loredana Capobianco1, Paola Lanuti6, Isabelle Fournier5, Michel Salzet5, Michele Maffia8, Daniele Vergara9.   

Abstract

Several studies have identified a specific metabolic program that is associated with the process of epithelial-mesenchymal transition (EMT). Whereas much is known about the association between glucose metabolism and EMT, the contribution of lipid metabolism is not still completely understood. Here, we studied epithelial and mesenchymal breast cancer cells by proteomic and lipidomic approaches and identified significant differences that characterised these models concerning specific metabolic enzymes and metabolites including fatty acids and phospholipids. Higher levels of monounsaturated fatty acids together with increased expression of enzymes of de novo fatty acid synthesis is the distinct signature of epithelial with respect to mesenchymal cells that, on the contrary, show reduced lipogenesis, higher polyunsaturated fatty acids level and increased expression of genes involved in the triacylglycerol (TAG) synthesis and lipid droplets formation. In the mesenchymal model, the diacylglycerol acyltransferase (DGAT)-1 appears to be the major enzyme involved in TAG synthesis and inhibition of DGAT1, but not DGAT2, drastically reduces the incorporation of labeled palmitate into TAG. Moreover, knockdown of β-catenin demonstrated that this metabolic phenotype in under the control of a network of transcriptional factors and that β-catenin has a specific role in the regulation of lipid metabolism in mesenchymal cells.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epithelial mesenchymal transition; Lipids; Mass spectrometry; Metabolism; β-Catenin

Mesh:

Substances:

Year:  2018        PMID: 30578966     DOI: 10.1016/j.bbalip.2018.12.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  28 in total

1.  Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells.

Authors:  Alicia Bort; Belén G Sánchez; Irene de Miguel; Pedro A Mateos-Gómez; Inés Diaz-Laviada
Journal:  Mol Biol Rep       Date:  2020-03-03       Impact factor: 2.316

Review 2.  Advances in Analyzing the Breast Cancer Lipidome and Its Relevance to Disease Progression and Treatment.

Authors:  Ashley V Ward; Steven M Anderson; Carol A Sartorius
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-12-16       Impact factor: 2.673

Review 3.  Interaction between adipose tissue and cancer cells: role for cancer progression.

Authors:  Jean-François Dumas; Lucie Brisson
Journal:  Cancer Metastasis Rev       Date:  2020-10-02       Impact factor: 9.264

Review 4.  Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing.

Authors:  Vinod S Bisht; Kuldeep Giri; Deepak Kumar; Kiran Ambatipudi
Journal:  Cancer Biol Ther       Date:  2021-10-25       Impact factor: 4.742

5.  Lipid-Based Nanovesicles for Simultaneous Intracellular Delivery of Hydrophobic, Hydrophilic, and Amphiphilic Species.

Authors:  Antonella Zacheo; Luca Bizzarro; Laura Blasi; Clara Piccirillo; Antonio Cardone; Giuseppe Gigli; Andrea Ragusa; Alessandra Quarta
Journal:  Front Bioeng Biotechnol       Date:  2020-07-03

6.  YDJC Induces Epithelial-Mesenchymal Transition via Escaping from Interaction with CDC16 through Ubiquitination of PP2A.

Authors:  Eun Ji Kim; Mi Kyung Park; Gyeoung-Jin Kang; Hyun Jung Byun; Hyun Ji Kim; Lu Yu; Boram Kim; Hee-Sung Chae; Young-Won Chin; Jae Gal Shim; Ho Lee; Chang Hoon Lee
Journal:  J Oncol       Date:  2019-08-07       Impact factor: 4.375

7.  Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.

Authors:  Zhanghan Chen; Zehuan Li; Haoran Li; Ying Jiang
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

8.  Proteomic Characterization of Cytoplasmic Lipid Droplets in Human Metastatic Breast Cancer Cells.

Authors:  Alyssa S Zembroski; Chaylen Andolino; Kimberly K Buhman; Dorothy Teegarden
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

9.  Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum.

Authors:  Priyanka Chakraborty; Emily L Chen; Isabelle McMullen; Andrew J Armstrong; Mohit Kumar Jolly; Jason A Somarelli
Journal:  Comput Struct Biotechnol J       Date:  2021-06-17       Impact factor: 7.271

10.  The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).

Authors:  Rosamaria Lappano; Marianna Talia; Francesca Cirillo; Damiano Cosimo Rigiracciolo; Domenica Scordamaglia; Rita Guzzi; Anna Maria Miglietta; Ernestina Marianna De Francesco; Antonino Belfiore; Andrew H Sims; Marcello Maggiolini
Journal:  J Exp Clin Cancer Res       Date:  2020-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.